Regulation of Apelin-13 on Bcl-2 and Caspase-3 and Its Effects on Adipocyte Apoptosis
Overview
Affiliations
Objective: The effects of apelin-13 on the expression of Bcl-2 and caspase-3 factors and the apoptosis of adipocytes were studied at the cellular and animal levels.
Methods: 3T3-L1 preadipocytes were cultured and grouped. The third-generation cells were added to the control DMSO solvent and amidation-modified apelin-13. The expression of Bcl-2 and caspase-3 were detected. The cell growth viability and cell apoptosis were detected. DOI model rats were established. The effects of apelin-13 on DOI rat biochemical indicators, the expression of Bcl-2, caspase-3, and cell apoptosis were investigated by injecting amidation-modified apelin-13 through the tail vein.
Result: In in vitro experiments, amidation-modified apelin-13 can significantly reduce the growth viability of adipocytes and the expression of Bcl-2, increase the expression of caspase-3, and promote the apoptosis of adipocytes. Animal experiments also show that apelin-13 modified by amidation can adjust the abnormal biochemical indicators of DOI rats, decrease the expression of Bcl-2 in adipose tissue, increase the expression of caspase-3, and promote the apoptosis of adipocytes.
Conclusion: Amidation of apelin-13 can promote fat cell apoptosis and reduce the incidence of obesity. The mechanism may be accomplished by inhibiting Bcl-2 and caspase-3 factors. This study helps us understand the effect of apelin-13 on fat cell apoptosis and hopes to provide a basis for the development of antiobesity drugs.
Imran S, Bibi Y, Yang L, Qayyum A, He W, Yang J Heliyon. 2024; 10(5):e27492.
PMID: 38463888 PMC: 10923843. DOI: 10.1016/j.heliyon.2024.e27492.
Kumar M, Kumar S, Chakrabartty S, Poulose A, Mostafa H, Goyal B Micromachines (Basel). 2023; 14(12).
PMID: 38138305 PMC: 10745406. DOI: 10.3390/mi14122136.
Retracted: Regulation of Apelin-13 on Bcl-2 and Caspase-3 and Its Effects on Adipocyte Apoptosis.
And Alternative Medicine E Evid Based Complement Alternat Med. 2023; 2023:9762535.
PMID: 38125151 PMC: 10733001. DOI: 10.1155/2023/9762535.
Beneficial effects of Apelin-13 on metabolic diseases and exercise.
Wen R, Huang R, Xu K, Cheng Y, Yi X Front Endocrinol (Lausanne). 2023; 14:1285788.
PMID: 38089606 PMC: 10714012. DOI: 10.3389/fendo.2023.1285788.
Saad B Biomedicines. 2023; 11(8).
PMID: 37626701 PMC: 10452657. DOI: 10.3390/biomedicines11082204.